Tower Research Capital (TRC)
NEOS

Tower Research Capital (TRC)’s Neos Therapeutics, Inc NEOS Stock Holding History

Tower Research Capital (TRC)’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,969
Closed -$13K – 5579
2020
Q3 		$13K Buy
24,969
+2,926
+13% +$1.99K ﹤0.01% 4012
2020
Q2 		$15K Sell
22,043
-2,306
-9% -$1.83K ﹤0.01% 3849
2020
Q1 		$18K Buy
24,349
+6,485
+36% +$8.91K ﹤0.01% 1787
2019
Q4 		$27K Buy
17,864
+4,302
+32% +$6.45K ﹤0.01% 1749
2019
Q3 		$20K Buy
13,562
+8,062
+147% +$13K ﹤0.01% 2491
2019
Q2 		$7K Sell
5,500
-2,435
-31% -$4.48K ﹤0.01% 2810
2019
Q1 		$21K Buy
7,935
+7,435
+1,487% +$17.4K ﹤0.01% 2255
2018
Q4 		$1K Sell
500
-9,203
-95% -$25.8K ﹤0.01% 3719
2018
Q3 		$47K Buy
+9,703
New +$55K ﹤0.01% 1801
2018
Q2 		– Sell
-2,491
Closed -$21K – 4282
2018
Q1 		$21K Buy
+2,491
New +$23.8K ﹤0.01% 2157
2017
Q4 		– Sell
-1,145
Closed -$10K – 4265
2017
Q3 		$10K Buy
+1,145
New +$8.7K ﹤0.01% 3091
2017
Q2 		– Sell
-3,017
Closed -$22.8K – 3746
2017
Q1 		$22K Sell
3,017
-605
-17% -$3.75K ﹤0.01% 1257
2016
Q4 		$21K Buy
+3,622
New +$24.5K ﹤0.01% 2106
2016
Q3 		– Sell
-976
Closed -$9K – 4814
2016
Q2 		$9K Buy
976
+400
+69% +$3.82K ﹤0.01% 2960
2016
Q1 		$6K Buy
+576
New +$6.08K ﹤0.01% 2595
2015
Q4 		– Sell
-2,781
Closed -$58K – 5304
2015
Q3 		$58K Buy
+2,781
New +$61.3K 0.01% 919

Other funds holding NEOS

Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tower Research Capital (TRC)'s NEOS Position: Q4 2020 in Review

Tower Research Capital (TRC) sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 24,969 shares — an estimated $13K sold.

Tower Research Capital (TRC) first reported a position in NEOS in Q3 2015 and held it in 16 quarters. The position peaked at $58K in Q3 2015. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • Tower Research Capital (TRC) reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 24,969 Neos Therapeutics, Inc shares in Q4 2020, an estimated $13K.
  • Tower Research Capital (TRC) first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 16 quarters.
  • Tower Research Capital (TRC)'s Neos Therapeutics, Inc position peaked at $58K in Q3 2015.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.